Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Global Fashion Group SA

Start price
Target price
Perf. (%)
€2.95
21.02.22
-
21.02.25
-92.19%
11.03.24

Probably not worthwhile Investment
Medigene AG

Start price
Target price
Perf. (%)
€2.91
21.02.22
-
21.02.29
-48.45%
11.03.24

Probably not worthwhile Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€65.99
21.02.22
-
21.01.26
-92.38%
11.03.24

Probably not worthwhile Investment
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€11.54
21.02.22
€15.00
21.02.23
2.90%
22.02.23

Could be worthwhile Investment >10% per year
Tokyo Electric Power

Start price
Target price
Perf. (%)
€2.77
21.02.22
€2.00
21.02.23
0.00%
25.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Nel ASA

Start price
Target price
Perf. (%)
€1.17
21.02.22
€2.50
21.02.23
6.02%
24.02.22

Future proof or reliable business model
Innovative
Valuable balance sheet
ROE higher than 10% per year
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€58.05
21.02.22
€75.00
21.02.23
-5.17%
22.02.22

Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€13.13
21.02.22
€25.00
21.02.23
-7.07%
23.02.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Einhell Germany VZO

Start price
Target price
Perf. (%)
€192.00
21.02.22
-
21.02.23
-11.15%
22.02.23

First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€10.10
21.02.22
-
21.02.23
-35.47%
22.02.23

Could be very worthwhile Investment >20% year
buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€6.20
21.02.22
€13.50
21.02.23
2.90%
07.03.22

Could be very worthwhile Investment >20% year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chesapeake Gold Corp.

Start price
Target price
Perf. (%)
€2.10
20.02.22
-
20.02.23
-30.95%
22.10.22

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Some uniques
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€11.05
20.02.22
-
20.02.23
-1.99%
05.03.22

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.31
20.02.22
-
20.02.23
-6.49%
05.03.22

Risky Investment
buy
Maisons du Monde SAS

Start price
Target price
Perf. (%)
€18.95
20.02.22
€21.00
20.03.22
-5.01%
21.03.22

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€29.39
20.02.22
-
20.02.23
-0.65%
05.03.22

Could be very worthwhile Investment >20% year
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
Westport Innovations Inc.

Start price
Target price
Perf. (%)
€1.31
20.02.22
€2.00
20.02.23
17.14%
17.03.22

Innovative
Differentiated customer and product portfolio
Known brand
Very Future proof/growth oriented business model
Arcimoto Inc

Start price
Target price
Perf. (%)
€4.70
20.02.22
€6.00
20.02.23
0.43%
22.02.22

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
wallstreet:online AG

Start price
Target price
Perf. (%)
€17.85
20.02.22
€20.00
20.02.23
-3.64%
22.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Revenue growth >5% per year expected
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€16.80
20.02.22
€25.00
20.02.23
-6.43%
22.02.22

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.70
20.02.22
-
20.02.23
-18.09%
05.03.22

Could be very worthwhile Investment >20% year
buy
Wasgau Produktions & Handels AG

Start price
Target price
Perf. (%)
€14.60
19.02.22
-
19.02.23
-2.05%
05.03.22

Top 10 in its market
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
BayWa AG VNA

Start price
Target price
Perf. (%)
€36.90
19.02.22
-
19.02.23
-2.44%
05.03.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group